IBP vs SYRE

Comparison between Installed Building Products Inc (IBP, Company) and Spyre Therapeutics Inc (SYRE, Company).

IBP is from the Consumer Cyclical sector, while SYRE is from the Healthcare sector.

5-Year PerformanceIBP has outperformed SYRE, delivering a return of +12.3% compared to -14.8%

IBP vs SYRE - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	IBP(COMPANY)	SYRE(COMPANY)
Market Cap	$5.75B	$5.72B
Max Drawdown	61.75%	99.11%
Sharpe Ratio	0.55	2.47
5Y Beta	1.10	1.74
Industry	Residential Construction	Biotechnology
P/E Ratio	22.70	-29.38
Forward P/E	19.68	N/A
PEG Ratio	3.34	N/A
Dividend Yield	0.74%	N/A
5Y Dividends CAGR	78.06%	N/A
5Y EPS CAGR	23.18%	-2.15%
Debt to Equity	160.45%	0.00%
Free Cash Flow Yield	5.47%	-3.25%
P/S Ratio	1.92	650.22
P/B Ratio	8.47	12.16

Market Cap

Winner

IBP

$5.75B

SYRE

$5.72B

Max Drawdown

Winner

IBP

61.75%

SYRE

99.11%

Sharpe Ratio

IBP

0.55

Winner

SYRE

2.47

5Y Beta

Winner

IBP

1.10

SYRE

1.74

Industry

IBP

Residential Construction

SYRE

Biotechnology

P/E Ratio

IBP

22.70

Winner

SYRE

-29.38

Forward P/E

IBP

19.68

SYRE

N/A

PEG Ratio

IBP

3.34

SYRE

N/A

Dividend Yield

IBP

0.74%

SYRE

N/A

5Y Dividends CAGR

IBP

78.06%

SYRE

N/A

5Y EPS CAGR

Winner

IBP

23.18%

SYRE

-2.15%

Debt to Equity

IBP

160.45%

Winner

SYRE

0.00%

Free Cash Flow Yield

Winner

IBP

5.47%

SYRE

-3.25%

P/S Ratio

Winner

IBP

1.92

SYRE

650.22

P/B Ratio

Winner

IBP

8.47

SYRE

12.16

IBP vs SYRE - Historical Returns

Returns include dividend reinvestment.

Period	IBP	SYRE
1 month	-30.12%	+3.72%
3 months	-36.30%	+81.45%
6 months	-25.71%	+120.18%
1 year	+17.80%	+343.14%
5 years(CAGR)	+12.31%	-14.82%
10 years(CAGR)	+19.95%	-9.03%
Max(CAGR)	+25.74%	-11.13%

IBP

-30.12%

Winner

SYRE

+3.72%

IBP

-36.30%

Winner

SYRE

+81.45%

IBP

-25.71%

Winner

SYRE

+120.18%

IBP

+17.80%

Winner

SYRE

+343.14%

5Y(CAGR)

Winner

IBP

+12.31%

SYRE

-14.82%

10Y(CAGR)

Winner

IBP

+19.95%

SYRE

-9.03%

Max(CAGR)

Winner

IBP

+25.74%

SYRE

-11.13%

IBP vs SYRE - Annual Returns (2014 - 2026)

Returns include dividend reinvestment.

Year	IBP	SYRE
2026	-25.61%	+140.84%
2025	+52.30%	+37.36%
2024	-2.36%	+8.79%
2023	+112.18%	+104.27%
2022	-34.89%	-90.57%
2021	+37.28%	-44.51%
2020	+47.60%	+1.55%
2019	+99.85%	-4.98%
2018	-55.52%	+39.22%
2017	+82.35%	+18.38%
2016	+74.78%	-55.48%
2015	+39.81%	N/A
2014	+39.22%	N/A

IBP vs SYRE Drawdown Comparison

The maximum drawdown for IBP was -61.75%, occurring on Oct 24, 2018. Recovery took 516 trading sessions.

The maximum drawdown for SYRE was -99.11%, occurring on Jun 21, 2023. This drawdown has not yet recovered.

The current IBP drawdown is -42.20%. The current SYRE drawdown is -75.43%.

Rank	IBP	SYRE
#1	-61.75% Jan 3, 2018 - Jan 23, 2020	-99.11% Apr 8, 2016 - Jun 21, 2023
#2	-61.69% Feb 21, 2020 - Jul 22, 2020	N/A
#3	-48.37% Dec 29, 2021 - Jun 27, 2023	N/A
#4	-42.20% Feb 13, 2026 - Jun 5, 2026	N/A
#5	-42.16% Jul 31, 2024 - Aug 13, 2025	N/A
#6	-37.26% Aug 11, 2015 - May 5, 2016	N/A
#7	-32.04% Aug 7, 2023 - Dec 6, 2023	N/A
#8	-28.48% Oct 12, 2020 - Jan 20, 2021	N/A
#9	-26.13% Mar 6, 2014 - Oct 23, 2014	N/A
#10	-24.27% May 4, 2021 - Nov 22, 2021	N/A
#11	-24.16% Apr 3, 2024 - Jul 26, 2024	N/A
#12	-19.93% Jul 20, 2016 - Nov 11, 2016	N/A
#13	-18.39% Feb 11, 2021 - Apr 16, 2021	N/A
#14	-15.76% Jan 20, 2021 - Feb 8, 2021	N/A
#15	-15.74% Sep 8, 2025 - Dec 10, 2025	N/A

Correlation

Correlation between IBP and SYRE is -0.64 which considered as a moderate negative correlation - the stocks show some tendency to move in opposite directions.

-0.64

-101